Genome-scale CRISPR-Cas9 knockout screening in human cells

Shalem, Ophir, Sanjana, Neville E., Hartenian, Ella, Shi, Xi, Scott, David A., Mikkelsen, Tarjei S., Heckl, Dirk, Ebert, Benjamin L. +3 more·2014·Science

Cited by (1,041)

Items 301–400 of 1,041

  1. Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
    Dufva, Olli, Koski, Jan, Maliniemi, Pilvi, Ianevski, Aleksandr, Klievink, Jay, Leitner, Judith, Pölönen, Petri, Hohtari, Helena, Saeed, Khalid, Hannunen, Tiina et al. · 2020 · Blood
  2. The ADP/ATP translocase drives mitophagy independent of nucleotide exchange
    Hoshino, Atsushi, Wang, Wei-jia, Wada, Shogo, McDermott-Roe, Chris, Evans, Chantell S., Gosis, Bridget, Morley, Michael P., Rathi, Komal S., Li, Jian, Li, Kristina et al. · 2019 · Nature
  3. A CRISPR view of development
    Melissa M. Harrison, Brian Jenkins, Kate M. O’Connor-Giles, Jill Wildonger · 2014 · Genes & Development
  4. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
    Singh, Ritambhara, Kuscu, Cem, Quinlan, Aaron, Qi, Yanjun, Adli, Mazhar · 2015 · Nucleic Acids Research
  5. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
    Mahadevan, Navin R., Knelson, Erik H., Wolff, Jacquelyn O., Vajdi, Amir, Saigí, Maria, Campisi, Marco, Hong, Deli, Thai, Tran C., Piel, Brandon, Han, Saemi et al. · 2021 · Cancer Discovery
  6. CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity
    Kramer, Nicholas J., Haney, Michael S., Morgens, David W., Jovičić, Ana, Couthouis, Julien, Li, Amy, Ousey, James, Ma, Rosanna, Bieri, Gregor, Tsui, C. Kimberly et al. · 2018 · Nature Genetics
  7. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
    Zandra E. Walton, Chirag H. Patel, Rebekah C. Brooks, Yongjun Yu, Arig Ibrahim‐Hashim, Malini Riddle, Alessandra Porcu, Tianying Jiang, Brett Logan Ecker, Feven Tameire et al. · 2018 · Cell
  8. CRISPR base editors: genome editing without double-stranded breaks
    Ayman Eid, Sahar Abdulaziz Alshareef, Magdy M. Mahfouz · 2018 · Biochemical Journal
  9. MAIT cells protect against pulmonary Legionella longbeachae infection
    Huimeng Wang, Criselle D’Souza, Xin Yi Lim, Lyudmila Kostenko, Troi J. Pediongco, Sidonia B. G. Eckle, Bronwyn S. Meehan, Mai Shi, Nancy Wang, Shihan Li et al. · 2018 · Nature Communications
  10. LZTR1 is a regulator of RAS ubiquitination and signaling
    Johannes W. Bigenzahn, Giovanna M. Collu, Felix Kartnig, Melanie Pieraks, Gregory Ian Vladimer, Leonhard X. Heinz, Vitaly Sedlyarov, Fiorella Schischlik, Astrid Fauster, Manuele Rebsamen et al. · 2018 · Science
  11. Potential of Genome Editing to Improve Aquaculture Breeding and Production
    Remi L. Gratacap, Anna Wargelius, Rolf B. Edvardsen, Ross D. Houston · 2019 · Trends in Genetics
  12. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
    Procopio, Maria-Giuseppina, Laszlo, Csaba, Al Labban, Dania, Kim, Dong Eun, Bordignon, Pino, Jo, Seung-Hee, Goruppi, Sandro, Menietti, Elena, Ostano, Paola, Ala, Ugo et al. · 2015 · Nature Cell Biology
  13. MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
    Ayaka Sugiura, Gabriela Andrejeva, Kelsey Voss, Darren R. Heintzman, Xincheng Xu, Matthew Z. Madden, Xiang Ye, Katherine L. Beier, Nowrin U. Chowdhury, Melissa M. Wolf et al. · 2021 · Immunity
  14. A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
    Hongming Ma, Ying Dang, Yonggan Wu, Gengxiang Jia, Edgar Anaya, Junli Zhang, Sojan Abraham, Jang-Gi Choi, Guojun Shi, Ling Qi et al. · 2015 · Cell Reports
  15. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
    Mark L. McCleland, Kathryn Mesh, Edward G. Lorenzana, Vivek S. Chopra, Ehud Segal, Colin K. Watanabe, Benjamin Haley, Oleg Mayba, Murat Yaylaoglu, Florian Gnad et al. · 2016 · Journal of Clinical Investigation
  16. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids
    Michels, Birgitta E., Mosa, Mohammed H., Streibl, Barbara I., Zhan, Tianzuo, Menche, Constantin, Abou-El-Ardat, Khalil, Darvishi, Tahmineh, Członka, Ewelina, Wagner, Sebastian, Winter, Jan et al. · 2020 · Cell Stem Cell
  17. RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
    Wang, Jianbin, Quake, Stephen R. · 2014 · Proceedings of the National Academy of Sciences
  18. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
    Chang Li, Xinmeng Guan, Tao Du, Wei Jin, Biao Wu, Yalan Liu, Ping Wang, Bodan Hu, George Edward Griffin, Robin J. Shattock et al. · 2015 · Journal of General Virology
  19. Loss-of-function genetic tools for animal models: cross-species and cross-platform differences
    Benjamin E. Housden, Matthias Muhar, Matthew P. Gemberling, Charles A. Gersbach, Didier Y. R. Stainier, Géraldine Seydoux, Stephanie Elizabeth Mohr, Johannes A. Zuber, Norbert Perrimon · 2016 · Nature Reviews Genetics
  20. Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation
    Keigo Morita, Yutaro Hama, Tamaki Izume, Norito Tamura, Toshihide Ueno, Yoshihiro Yamashita, Yuriko Sakamaki, Kaito Mimura, Hideaki Morishita, Wataru Shihoya et al. · 2018 · The Journal of Cell Biology
  21. DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells
    Yizhou Joseph He, Khyati A. Meghani, Marie‐Christine Caron, Chunyu Yang, Daryl A. Ronato, Jie Bian, Anchal Sharma, Jessica L. Moore, Niraj Joshi, Alexandre Detappe et al. · 2018 · Nature
  22. Identifying chemogenetic interactions from CRISPR screens with drugZ
    Medina Colic, Gang Wang, Michal Zimmermann, Keith S. Mascall, Megan E. McLaughlin, Lori L. Bertolet, W. Frank Lenoir, Jason Moffat, Stéphane Angers, Daniel Durocher et al. · 2019 · Genome Medicine
  23. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening
    Roberta Esposito, Núria Bosch, Andrés Lanzós, Taisia Polidori, Carlos Pulido-Quetglas, Rory Johnson · 2019 · Cancer Cell
  24. Cellular locomotion using environmental topography
    Anne Reversat, Florian Gaertner, Jack Merrin, Julian Stopp, Saren Tasciyan, Juan Aguilera-Servin, Ingrid de Vries, Robert Hauschild, Miroslav Hons, Matthieu Piel et al. · 2020 · Nature
  25. Optimization of AsCas12a for combinatorial genetic screens in human cells
    Peter C. DeWeirdt, Kendall R Sanson, Annabel K. Sangree, Mudra Hegde, Ruth E. Hanna, Marissa N. Feeley, Audrey L Griffith, Teng Teng, Samantha M. Borys, Christine Strand et al. · 2020 · Nature Biotechnology
  26. Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
    Zhang, Lingmin, Wang, Peng, Feng, Qiang, Wang, Nuoxin, Chen, Zitian, Huang, Yanyi, Zheng, Wenfu, Jiang, Xingyu · 2017 · NPG Asia Materials
  27. Pathways and therapeutic targets in melanoma
    Emma Shtivelman, Michael A. Davies, Patrick Hwu, James Chih-Hsin Yang, Michal Lotem, Moshe Oren, Keith T. Flaherty, David E. Fisher · 2014 · Oncotarget
  28. A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models
    Sjoerd Opdam, Anne Richelle, Benjamin P. Kellman, Shanzhong Li, Daniel Craig Zielinski, Nathan E. Lewis · 2017 · Cell Systems
  29. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
    Douglas B. Fox, Nina Marie G. Garcia, Brock J. McKinney, Ryan Lupo, Laura C. Noteware, Rachel Newcomb, Juan Liu, Jason W. Locasale, Matthew D. Hirschey, James V. Alvarez · 2020 · Nature Metabolism
  30. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
    Weijun Zhu, Rongyue Lei, Yann Le Duff, Jian Li, Fei Guo, Mark A. Wainberg, Chen Liang · 2015 · Retrovirology
  31. Small RNAs: A New Paradigm in Plant-Microbe Interactions
    Arne Weiberg, Ming Wang, Marschal Bellinger, Hailing Jin · 2014 · Annual Review of Phytopathology
  32. 53BP1 and USP28 mediate p53-dependent cell cycle arrest in response to centrosome loss and prolonged mitosis
    Chii Shyang Fong, Gregory Mazo, Tuhin Das, Joshua H. Goodman, Minhee Kim, Brian P O'Rourke, Denisse Izquierdo, Meng-Fu Bryan Tsou · 2016 · eLife
  33. Application of CRISPR-Cas9 genome editing technology in various fields: A review
    Arif Nur Muhammad Ansori, Yulanda Antonius, Raden Joko Kuncoroningrat Susilo, Suhailah Hayaza, Viol Dhea Kharisma, Arli Aditya Parikesit, Rahadian Zainul, Vikash Jakhmola, Taru Saklani, Максим Борисович Ребезов et al. · 2023 · Narra J
  34. STING enhances cell death through regulation of reactive oxygen species and DNA damage
    Thomas J. Hayman, Marta Baro, Tyler MacNeil, Chatchai Phoomak, Thazin Nwe Aung, Wei Cui, Kevin Leach, Radhakrishnan P. Iyer, Sreerupa Challa, Teresa Sandoval-Schaefer et al. · 2021 · Nature Communications
  35. CRISPR/Cas9 and Genome Editing in Drosophila
    Andrew Roger Bassett, Ji‐Long Liu · 2013 · Journal of genetics and genomics/Journal of Genetics and Genomics
  36. CRISPR-ERA: a comprehensive design tool for CRISPR-mediated gene editing, repression and activation: Fig. 1.
    Honglei Liu, Wei Zheng, Antonia A. Dominguez, Yanda Li, Xiaowo Wang, Lei S. Qi · 2015 · Computer applications in the biosciences
  37. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
    Panpan Hou, Shuliang Chen, Shilei Wang, Xiao Yu, Yu Zheng Chen, Meng Jiang, Ke Zhuang, Wen‐Zhe Ho, Wei Hou, Jian Yuan Huang et al. · 2015 · Scientific Reports
  38. Prediction of the sequence-specific cleavage activity of Cas9 variants
    Kim, Nahye, Kim, Hui Kwon, Lee, Sungtae, Seo, Jung Hwa, Choi, Jae Woo, Park, Jinman, Min, Seonwoo, Yoon, Sungroh, Cho, Sung-Rae, Kim, Hyongbum Henry · 2020 · Nature Biotechnology
  39. High-throughput Phenotyping of Lung Cancer Somatic Mutations
    Alice H. Berger, Angela Norie Brooks, Xiaoyun Wu, Yashaswi Shrestha, Candace R. Chouinard, Federica Piccioni, Mukta Bagul, Atanas Kamburov, Marcin B. Imielinski, Larson J. Hogstrom et al. · 2016 · Cancer Cell
  40. Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting
    H. Furkan Alkan, Katharina E. Walter, Alba Luengo, Corina T. Madreiter‐Sokolowski, Sarah Stryeck, Allison N. Lau, Wael Al Zoughbi, Caroline A. Lewis, Craig J. Thomas, Gerald Höefler et al. · 2018 · Cell Metabolism
  41. CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming
    Yanxia Liu, Yu Chen, Timothy Daley, Fangyuan Wang, William Cao, Salil S. Bhate, Xueqiu Lin, Chris Still, Honglei Liu, Dehua Zhao et al. · 2018 · Cell stem cell
  42. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
    Wenyan Jiang, Luciano A. Marraffini · 2015 · Annual Review of Microbiology
  43. Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma
    Sophia Gayle, Sean F. Landrette, Neil Beeharry, Chris Conrad, Marylens Hernandez, Paul Beckett, Shawn M. Ferguson, Talya F. Mandelkern, Meiling Zheng, Tian Xu et al. · 2017 · Blood
  44. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes
    Ashish Goyal, Ksenia Myacheva, Matthias Groß, Marcel Klingenberg, Berta Duran Arqué, Sven Diederichs · 2016 · Nucleic Acids Research
  45. Automated multiplex genome-scale engineering in yeast
    Tong Si, Ran Chao, Yuhao Min, Yuying Wu, Wen Ren, Huimin Zhao · 2017 · Nature Communications
  46. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications
    Adekunle Ebenezer Omole, Adegbenro Omotuyi John Fakoya · 2018 · PeerJ
  47. Omics Advances in Ecotoxicology
    Xiaowei Zhang, Pu Xia, Pingping Wang, Jianghu Yang, Donald J. Baird · 2018 · Environmental Science & Technology
  48. Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer
    Elza C. de Bruin, Catherine Cowell, Patricia H. Warne, Ming Zuo Jiang, Rebecca E. Saunders, Mary Ann Melnick, Scott N. Gettinger, Zenta Walther, Anna Wurtz, Guus J.J.E. Heynen et al. · 2014 · Cancer Discovery
  49. Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance
    Ringel, Till, Frey, Nina, Ringnalda, Femke, Janjuha, Sharan, Cherkaoui, Sarah, Butz, Stefan, Srivatsa, Sumana, Pirkl, Martin, Russo, Giancarlo, Villiger, Lukas et al. · 2020 · Cell Stem Cell
  50. The sound of silence: Transgene silencing in mammalian cell engineering
    Alan Cabrera, Hailey I. Edelstein, Fokion Glykofrydis, Kasey S. Love, Sebastian Palacios, Josh Tycko, Meng Zhang, Sarah Lensch, Cara E. Shields, Mark Livingston et al. · 2022 · Cell Systems
  51. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing
    Nicole M. Martínez, Amanda Su, Margaret C. Burns, Julia K. Nussbacher, Cassandra Schaening-Burgos, Shashank Sathe, Gene Wei-Ming Yeo, Wendy V. Gilbert · 2022 · Molecular Cell
  52. In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
    Lupeng Ye, Jonathan Joon-Young Park, Matthew B. Dong, Quanjun Yang, Ryan Dz-Wei Chow, Lei Peng, Yaying Du, Jianjian Guo, Xiaoyun Dai, Guangchuan Wang et al. · 2019 · Nature Biotechnology
  53. TMEM41B Is a Pan-flavivirus Host Factor
    Hans-Heinrich Hoffmann, William M. Schneider, Kathryn Rozen-Gagnon, Linde A. Miles, Felix Schuster, Brandon S. Razooky, Eliana Jacobson, Xianfang Wu, Soon Yi, Charles M. Rudin et al. · 2020 · Cell
  54. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells
    Yilan Zhang, Xianglian Ge, Fayu Yang, Liping Zhang, Jiayong Zheng, Xuefang Tan, Zi‐Bing Jin, Jia Qu, Feng Gu · 2014 · Scientific Reports
  55. The SKIV2L RNA exosome limits activation of the RIG-I-like receptors
    Sterling C. Eckard, Gillian Rice, Alexandre Fabre, Catherine Badens, Elizabeth E. Gray, Jane Hartley, Yanick Joseph Crow, Daniel B. Stetson · 2014 · Nature Immunology
  56. Cytokines in cancer drug resistance: Cues to new therapeutic strategies
    Valerie Sloane Jones, Ren-Yu Huang, Li-Pai Chen, Zhe‐Sheng Chen, Liwu Fu, Ruo-Pan Huang · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  57. Engineering biological systems using automated biofoundries
    Ran Chao, Shekhar Mishra, Tong Si, Huimin Zhao · 2017 · Metabolic Engineering
  58. Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
    Kristen E. Mengwasser, Richard O. Adeyemi, Yumei Leng, Mei Yuk Choi, Connor S. Clairmont, Alan D. D’Andrea, Stephen Joseph Elledge · 2019 · Molecular Cell
  59. Various Aspects of a Gene Editing System—CRISPR–Cas9
    Edyta Janik, Marcin Niemcewicz, Michał Ceremuga, Łukasz Krzowski, Joanna Saluk, Michał Bijak · 2020 · International Journal of Molecular Sciences
  60. Highly Parallel Profiling of Cas9 Variant Specificity
    Schmid-Burgk, Jonathan L., Gao, Linyi, Li, David, Gardner, Zachary, Strecker, Jonathan, Lash, Blake, Zhang, Feng · 2020 · Molecular Cell
  61. LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP
    Lauren J. Lahey, Rachel E. Mardjuki, Xianlan Wen, Gaelen T. Hess, Christopher Ritchie, Jacqueline A. Carozza, Volker Böhnert, Merritt C. Maduke, Michael Cory Bassik, Lingyin Li · 2020 · Molecular Cell
  62. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
    Wen‐Wei Zhang, Greg Matlashewski · 2015 · mBio
  63. Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers
    Xuefei Gao, Jason C.H. Tsang, Fortis Gaba, Donghai Wu, Liming Lu, Pentao Liu · 2014 · Nucleic Acids Research
  64. Differential Stoichiometry among Core Ribosomal Proteins
    Nikolai Slavov, Stefan Semrau, Edoardo M. Airoldi, Bogdan Budnik, Alexander van Oudenaarden · 2015 · Cell Reports
  65. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
    Chad M. Toledo, Yu Ding, Pia Hoellerbauer, Ryan J. Davis, Ryan Basom, Emily J. Girard, Eunjee Lee, Philip D. Corrin, Traver Hart, Hamid Bolouri et al. · 2015 · Cell Reports
  66. Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design
    Justin Smith, Sundari Suresh, Ulrich Schlecht, Manhong Wu, Omar Wagih, Gary Peltz, Ronald Wayne Davis, Lars Michael Steinmetz, Leopold Parts, Robert P. St.Onge · 2016 · Genome biology
  67. A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies
    David K. Breslow, Sascha Hoogendoorn, Adam R. Kopp, David W. Morgens, Brandon K. Vu, Margaret C. Kennedy, Kyuho Han, Amy Li, Gaelen T. Hess, Michael Cory Bassik et al. · 2018 · Nature Genetics
  68. A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation
    Lopez-Pajares, Vanessa, Qu, Kun, Zhang, Jiajing, Webster, Dan E., Barajas, Brook C., Siprashvili, Zurab, Zarnegar, Brian J., Boxer, Lisa D., Rios, Eon J., Tao, Shiying et al. · 2015 · Developmental Cell
  69. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages
    Lan H. Chu, Mohanalaxmi Indramohan, Rojo A. Ratsimandresy, Anu Gangopadhyay, Emily P. Morris, Denise M. Monack, Andrea Dorfleutner, Christian Stehlik · 2018 · Nature Communications
  70. Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map
    Ian C. P. Smith, Peyton Greenside, Ted E. Natoli, David L. Lahr, David Wadden, Itay Tirosh, Rajiv Narayan, David E. Root, Todd R. Golub, Aravind Subramanian et al. · 2017 · PLoS Biology
  71. Mapping the genetic landscape of DNA double-strand break repair
    Jeffrey A. Hussmann, Ling Jia, Purnima Ravisankar, Jun Yan, Ann Cirincione, Albert Xu, Danny Simpson, Dian Yang, Anne Bothmer, Cecilia Cotta‐Ramusino et al. · 2021 · Cell
  72. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
    Julia Weber, Rupert Öllinger, Mathias Friedrich, Ursula Ehmer, Maxim Barenboim, Katja Steiger, Irina Heid, Sebastian Mueller, Roman Maresch, Thomas Engleitner et al. · 2015 · Proceedings of the National Academy of Sciences
  73. Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides
    Hana M. Russo, Joseph K. Rathkey, Andrea Boyd Tressler, Michael A Katsnelson, Derek W. Abbott, George Dubyak · 2016 · The Journal of Immunology
  74. Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens
    Haney, Michael S., Bohlen, Christopher J., Morgens, David W., Ousey, James A., Barkal, Amira A., Tsui, C. Kimberly, Ego, Braeden K., Levin, Roni, Kamber, Roarke A., Collins, Hannah et al. · 2018 · Nature Genetics
  75. Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
    Jennifer L. Gori, Patrick D. Hsu, Morgan L. Maeder, Shen Shen, G. Grant Welstead, David A. Bumcrot · 2015 · Human Gene Therapy
  76. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
    Michele Ardolino, Camillia S. Azimi, Alexandre Iannello, Troy N. Trevino, Lucas H. Horan, Lily Zhang, Weiwen Deng, Aaron M. Ring, Suzanne Fischer, K. Christopher García et al. · 2014 · Journal of Clinical Investigation
  77. A CRISPR toolbox to study virus–host interactions
    Andreas S. Puschnik, Karim Majzoub, Yaw Shin Ooi, Jan E. Carette · 2017 · Nature Reviews Microbiology
  78. Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation
    Daniel Fuentes, Tomek Swigut, Joanna Wysocka · 2018 · eLife
  79. Molecular insights into NF2/Merlin tumor suppressor function
    Jonathan M. Cooper, Filippo G. Giancotti · 2014 · FEBS Letters
  80. Fast and sensitive detection of indels induced by precise gene targeting
    Yang Zhang, Catharina Steentoft, Camilla Hauge, Lars Hestbjerg Hansen, Allan Lind-Thomsen, Francesco Niola, Malene Bech Vester-Christensen, Morten Frödin, Henrik Clausen, Hans Heugh Wandall et al. · 2015 · Nucleic Acids Research
  81. CRISPy-web: An online resource to design sgRNAs for CRISPR applications
    Kai Blin, Lasse Ebdrup Pedersen, Tilmann Weber, Sang Yup Lee · 2016 · Synthetic and Systems Biotechnology
  82. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals
    Francisco J. M. Mojica, Lluı́s Montoliu · 2016 · Trends in Microbiology
  83. Gene correction for SCID-X1 in long-term hematopoietic stem cells
    Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene, Waracharee Srifa, Sruthi Mantri, Carmencita E. Nicolas, Ciaran M. Lee, Gang Bao, Eric Kildebeck, Niraj Punjya et al. · 2019 · Nature Communications
  84. Cellular barcoding: lineage tracing, screening and beyond
    Justus M. Kebschull, Anthony M. Zador · 2018 · Nature Methods
  85. Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
    Priscilla Cheung, Jordi Xiol, Michael T. Dill, Wei-Chien Yuan, Riccardo Panero, Jatin Roper, Fernando G. Osorio, Dejan Maglic, Qi Li, Basanta Gurung et al. · 2020 · Cell stem cell
  86. 3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis
    Nobuaki Takahashi, Patricia Cho, Laura M. Selfors, Hendrik J. Kuiken, Roma Kaul, Takuro Fujiwara, Isaac S. Harris, Tian Zhang, Steven P. Gygi, Joan S. Brugge · 2020 · Molecular Cell
  87. Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
    Zhiyuan Niu, Qian Shi, Wenlong Zhang, Yuxin Shu, Nanfei Yang, Bing Chen, Qingsong Wang, Xuyang Zhao, Jiajia Chen, Nan Cheng et al. · 2017 · Nature Communications
  88. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
    Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, Stefania Rossi, Maria Elena Pisanu, Maria Bellenghi, Carla Lintas, Claudio Tabolacci · 2023 · Cancers
  89. The whole-genome landscape of Burkitt lymphoma subtypes
    Razvan Panea, Cassandra Love, Jennifer R. Shingleton, Anupama Reddy, Jeffrey A. Bailey, Ann Marie Moormann, Juliana A. Otieno, John Michael Ong’echa, Cliff I. Oduor, Kristin Schroeder et al. · 2019 · Blood
  90. Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
    Roth, Theodore L., Li, P. Jonathan, Blaeschke, Franziska, Nies, Jasper F., Apathy, Ryan, Mowery, Cody, Yu, Ruby, Nguyen, Michelle L.T., Lee, Youjin, Truong, Anna et al. · 2020 · Cell
  91. The CRISPR/Cas9 system and its applications in crop genome editing
    Bao, Aili, Burritt, David J., Chen, Haifeng, Zhou, Xinan, Cao, Dong, Tran, Lam-Son Phan · 2019 · Critical Reviews in Biotechnology
  92. Off-target predictions in CRISPR-Cas9 gene editing using deep learning
    Lin, Jiecong, Wong, Ka-Chun · 2018 · Bioinformatics
  93. The CENP-L-N Complex Forms a Critical Node in an Integrated Meshwork of Interactions at the Centromere-Kinetochore Interface
    Kara L. McKinley, Nikolina Sekulić, Lucie Y. Guo, Tonia K. Tsinman, Ben E. Black, Iain M. Cheeseman · 2015 · Molecular Cell
  94. Precision genome editing in the CRISPR era
    Jayme Salsman, Graham Dellaire · 2016 · Biochemistry and Cell Biology
  95. Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex
    Shen, Hongjie, Xu, Wenqi, Guo, Rui, Rong, Bowen, Gu, Lei, Wang, Zhentian, He, Chenxi, Zheng, Lijuan, Hu, Xin, Hu, Zhen et al. · 2016 · Cell
  96. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
    Richard M. Deans, D. Morgens, Ayşe Ökesli, S. Pillay, M. Horlbeck, M. Kampmann, Luke A. Gilbert, Amy Li, Roberto Mateo, Mark Smith et al. · 2016 · Nature Chemical Biology
  97. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases
    Hyewon Jang, Dong Hyun Jo, Chang Sik Cho, Jeong Hong Shin, Jung Hwa Seo, Goosang Yu, Ramu Gopalappa, Daesik Kim, Sung‐Rae Cho, Jeong Hun Kim et al. · 2021 · Nature Biomedical Engineering
  98. Development of CRISPR-Cas systems for genome editing and beyond
    F. Zhang · 2019 · Quarterly Reviews of Biophysics
  99. Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer
    Jaclyn M. Einstein, Mark Perelis, Isaac Alexander Chaim, Jitendra Kumar Meena, Julia K. Nussbacher, Alexandra T. Tankka, Brian A. Yee, Heyuan Li, Assael A. Madrigal, Nicholas J. Neill et al. · 2021 · Molecular Cell
  100. Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
    Stanislaus Antony Ceasar, Vinothkumar Rajan, Sergey V. Prykhozhij, Jason N. Berman, Savarimuthu Ignacimuthu S.J. · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research